NASDAQ · HCAT
Healthcare · Medical - Healthcare Information Services
$1.79
Down-$0.10 (-5.59%)
Updated Oct 31, 2026, 12:31 AM
SID Score
3.2/10
Composite research score
Smart Money
—
Institutional and insider signal
Price performance · HCAT
1M range · 21 trading sessions · Daily adjusted prices
Prices through Oct 30, 2026
HCAT closed at $1.69 after 21 trading sessions, down 3.43% for the selected period.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 30, 2026 | $1.79 | $1.84 | $1.66 | $1.69 | 344.99K |
| Oct 29, 2026 | $1.80 | $1.835 | $1.77 | $1.79 | 282.31K |
| Oct 28, 2026 | $1.60 | $1.835 | $1.57 | $1.80 | 695.48K |
| Oct 27, 2026 | $1.63 | $1.64 | $1.565 | $1.57 | 355.75K |
| Oct 26, 2026 | $1.66 | $1.675 | $1.62 | $1.63 | 197.86K |
| Oct 23, 2026 | $1.73 | $1.735 | $1.69 | $1.69 | 167.4K |
| Oct 22, 2026 | $1.75 | $1.775 | $1.71 | $1.74 | 165.62K |
| Oct 21, 2026 | $1.79 | $1.79 | $1.74 | $1.74 | 91.72K |
| Oct 20, 2026 | $1.71 | $1.76 | $1.6806 | $1.75 | 139.56K |
| Oct 19, 2026 | $1.72 | $1.75 | $1.68 | $1.71 | 404.75K |
| Oct 16, 2026 | $1.80 | $1.838 | $1.72 | $1.725 | 178.67K |
| Oct 15, 2026 | $1.74 | $1.81 | $1.74 | $1.80 | 306.82K |
| Oct 14, 2026 | $1.71 | $1.755 | $1.71 | $1.74 | 458.32K |
| Oct 13, 2026 | $1.75 | $1.79 | $1.65 | $1.74 | 1.38M |
| Oct 12, 2026 | $1.79 | $1.81 | $1.71 | $1.75 | 345.32K |
| Oct 9, 2026 | $1.76 | $1.79 | $1.70 | $1.77 | 1.02M |
| Oct 8, 2026 | $1.75 | $1.76 | $1.71 | $1.75 | 564.56K |
| Oct 7, 2026 | $1.75 | $1.785 | $1.724 | $1.76 | 240.67K |
| Oct 6, 2026 | $1.77 | $1.82 | $1.75 | $1.77 | 225.22K |
| Oct 5, 2026 | $1.75 | $1.79 | $1.725 | $1.76 | 230.25K |
| Oct 2, 2026 | $1.71 | $1.76 | $1.695 | $1.75 | 243.4K |
The latest Smart Investors Daily articles mentioning HCAT.
Company
Market Activity
Research & News
HCAT research
Company profile and research snapshot.
Health Catalyst Inc provides data and analytics technology and services to healthcare organizations. It has two operating segments. The Technology segment, the key revenue driver, includes data platforms, analytics applications, and support services. This generates revenues mainly from contracts that are cloud-based subscription arrangements, time-based license arrangements, and maintenance and support fees; the Professional Services segment is generally the combination of analytics, implementation, strategic advisory, outsourcing, and improvement services to deliver expertise to its customers to more fully configure and utilize the benefits of the technology offerings.
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| Aug 21, 2026 | Canaccord Genuity | Hold | — |
| Aug 13, 2026 | Wells Fargo | Equal-Weight | — |
| Aug 11, 2026 | Citigroup | Neutral | — |
| Jul 21, 2026 | Canaccord Genuity | Buy | — |
| Jun 26, 2026 | Wells Fargo | Equal-Weight | — |
No generated briefing is available yet.
Yahoo · Oct 29, 2026
Market swings can be tough to stomach, and volatile stocks often experience exaggerated moves in both directions. While many thrive during risk-on environments, many also struggle to maintain investor confidence when the ride gets bumpy.
Yahoo · Oct 22, 2026
SALT LAKE CITY, Oct. 22, 2026 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst", Nasdaq: HCAT), a healthcare intelligence company designed to accelerate measurable improvement for health systems, will release its third quarter 2026 operating results on Thursday, November 5, 2026, after market close. In conjunction, the company will host a conference call to review the results at 5:00 pm ET on the same day. Conference Call Details The conference call can be accessed by dialing 800-274-
Yahoo · Oct 15, 2026
Let’s dig into the relative performance of Health Catalyst (NASDAQ:HCAT) and its peers as we unravel the now-completed Q2 data analytics earnings season.
Yahoo · Sep 30, 2026
What a time it’s been for Health Catalyst. In the past six months alone, the company’s stock price has increased by a massive 48.7%, reaching $1.76 per share. This performance may have investors wondering how to approach the situation.
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
The latest Smart Investors Daily articles mentioning HCAT.
